متلازمة نقص الحمض النووي المتقدري (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "متلازمة نقص الحمض النووي المتقدري" in Arabic language version.

refsWebsite

Global rank Arabic rank

4^th place

6^th place

2^nd place

5^th place

1^st place

2,888^th place

2,324^th place

230^th place

280^th place

doi.org

Saito K، Kimura N، Oda N، Shimomura H، Kumada T، Miyajima T، Murayama K، Tanaka M، Fujii T (مايو 2012). "Pyruvate therapy for mitochondrial DNA depletion syndrome". Biochimica et Biophysica Acta. ج. 1820 ع. 5: 632–6. DOI:10.1016/j.bbagen.2011.08.006. PMID:21855607.
Finsterer، J؛ Ahting، U (سبتمبر 2013). "Mitochondrial depletion syndromes in children and adults". The Canadian Journal of Neurological Sciences. ج. 40 ع. 5: 635–44. DOI:10.1017/S0317167100014852. PMID:23968935.
Carrozzo R، Verrigni D، Rasmussen M، de Coo R، Amartino H، Bianchi M، وآخرون (مارس 2016). "Succinate-CoA ligase deficiency due to mutations in SUCLA2 and SUCLG1: phenotype and genotype correlations in 71 patients". Journal of Inherited Metabolic Disease. ج. 39 ع. 2: 243–52. DOI:10.1007/s10545-015-9894-9. PMID:26475597.
Elpeleg O (2003). "Inherited mitochondrial DNA depletion". Pediatr Res. ج. 54 ع. 2: 153–9. DOI:10.1203/01.PDR.0000072796.25097.A5. PMID:12736387.
El-Hattab AW، Scaglia F (أبريل 2013). "Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options". Neurotherapeutics. ج. 10 ع. 2: 186–98. DOI:10.1007/s13311-013-0177-6. PMC:3625391. PMID:23385875.

Saito K، Kimura N، Oda N، Shimomura H، Kumada T، Miyajima T، Murayama K، Tanaka M، Fujii T (مايو 2012). "Pyruvate therapy for mitochondrial DNA depletion syndrome". Biochimica et Biophysica Acta. ج. 1820 ع. 5: 632–6. DOI:10.1016/j.bbagen.2011.08.006. PMID:21855607.
Finsterer، J؛ Ahting، U (سبتمبر 2013). "Mitochondrial depletion syndromes in children and adults". The Canadian Journal of Neurological Sciences. ج. 40 ع. 5: 635–44. DOI:10.1017/S0317167100014852. PMID:23968935.
Carrozzo R، Verrigni D، Rasmussen M، de Coo R، Amartino H، Bianchi M، وآخرون (مارس 2016). "Succinate-CoA ligase deficiency due to mutations in SUCLA2 and SUCLG1: phenotype and genotype correlations in 71 patients". Journal of Inherited Metabolic Disease. ج. 39 ع. 2: 243–52. DOI:10.1007/s10545-015-9894-9. PMID:26475597.
Elpeleg O (2003). "Inherited mitochondrial DNA depletion". Pediatr Res. ج. 54 ع. 2: 153–9. DOI:10.1203/01.PDR.0000072796.25097.A5. PMID:12736387.
El-Hattab AW، Scaglia F (أبريل 2013). "Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options". Neurotherapeutics. ج. 10 ع. 2: 186–98. DOI:10.1007/s13311-013-0177-6. PMC:3625391. PMID:23385875.
Cohen، BH؛ Chinnery، PF؛ Copeland، WC (18 ديسمبر 2014). Pagon، RA؛ وآخرون (المحررون). "POLG-Related Disorders". GeneReviews. PMID:20301791.

El-Hattab AW، Scaglia F (أبريل 2013). "Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options". Neurotherapeutics. ج. 10 ع. 2: 186–98. DOI:10.1007/s13311-013-0177-6. PMC:3625391. PMID:23385875.
Gorman، Gráinne S.؛ Taylor، Robert W. (17 أبريل 2014). "RRM2B-Related Mitochondrial Disease". GeneReviews. University of Washington, Seattle.

"Alpers' Disease Information Page". National Institute of Neurological Disorders and Stroke. مؤرشف من الأصل في 2019-10-08. اطلع عليه بتاريخ 2017-07-24.

This form of MDDS is also called "Alpers' disease", also called "Alpers' syndrome", "Alpers-Huttenlocher syndrome", "progressive sclerosing poliodystrophy", and "progressive infantile poliodystrophy". It is named after Bernard Jacob Alpers (Alpers' disease على قاموس من سمى هذا؟) and Peter Huttenlocher (see Easton، John (19 أغسطس 2013). "Peter Huttenlocher, pediatric neurologist, 1931–2013". The University of Chicago. مؤرشف من الأصل في 2018-06-01. اطلع عليه بتاريخ 2013-11-01.)

This form of MDDS is also called "Alpers' disease", also called "Alpers' syndrome", "Alpers-Huttenlocher syndrome", "progressive sclerosing poliodystrophy", and "progressive infantile poliodystrophy". It is named after Bernard Jacob Alpers (Alpers' disease على قاموس من سمى هذا؟) and Peter Huttenlocher (see Easton، John (19 أغسطس 2013). "Peter Huttenlocher, pediatric neurologist, 1931–2013". The University of Chicago. مؤرشف من الأصل في 2018-06-01. اطلع عليه بتاريخ 2013-11-01.)
"Alpers' Disease Information Page". National Institute of Neurological Disorders and Stroke. مؤرشف من الأصل في 2019-10-08. اطلع عليه بتاريخ 2017-07-24.

This form of MDDS is also called "Alpers' disease", also called "Alpers' syndrome", "Alpers-Huttenlocher syndrome", "progressive sclerosing poliodystrophy", and "progressive infantile poliodystrophy". It is named after Bernard Jacob Alpers (Alpers' disease على قاموس من سمى هذا؟) and Peter Huttenlocher (see Easton، John (19 أغسطس 2013). "Peter Huttenlocher, pediatric neurologist, 1931–2013". The University of Chicago. مؤرشف من الأصل في 2018-06-01. اطلع عليه بتاريخ 2013-11-01.)